cSSSI AND CONCURRENT BACTEREMIA1,13
In Phase 3 cSSSI clinical trials, VIBATIV was studied in patients with cSSSI and S. aureus bacteremia at the start of treatment.
*VIBATIV is not indicated for the treatment of bacteremia.
